Scientist, Cancer Research

ICR is dedicated to solving some of the most difficult problems in aging and age-related disease, including cancer early detection and prevention.

‍

With ICR, you'll get to:

Contribute highly practical and readily translatable pan-cancer screening/early detection, diagnostic, prevention and therapeutic ideas
Contribute to the development of novel personalized peptide and mRNA cancer vaccines
Quantify and track cancer biomarkers, including CTCs, cfDNA, serum, plasma, and urine proteins, RNA, metabolites, driver-gene mutations, epigenetic modifications, etc
Collaborate with ICR's Biomarkers Team to perform molecular and cellular cancer prevention screening assays, under a personalized medicine paradigm

Please apply if you have:

A PhD, MD or both At least 5 years of pan-cancer research experience
Current and in-depth knowledge of pan-cancer: screening, early detection, biomarkers, diagnostic prediction, genetics, prevention, and chemical and vaccine-therapeutics (practical and experimental)

Ideally, you'll also have:

Expert knowledge and understanding of worldwide pan-cancer drug development pipelines
Experience with cell-based assays, immunofluorescent microscopy, qPCR, flow cytometry, single-cell genomics, RNAseq, cell culture, organoid culture, Illumina NextSeq 550, DNA methylation sequencing, ddPCR, Luminex, clinical chemistry instrumentation, Kryptor, Access 2, robotic liquid handling (e.g. Tecan), Vortex, and DepArray
Knowledge and experience in cutting-edge paradigms of immuno-oncology including cell therapies, CAR-T, peptide vaccines, RNA vaccines, dendritic cell vaccines, neo-antigen vaccines, clinical vaccine safety, T cell and antibody analysis of vaccine-induced immunogenicity, etc
Experience with protein, RNA, and small metabolite cancer biomarker analysis

And you'll need:

Starting base pay range: $135,000/yr - $185,000/yr

Starting additional compensation range: $7,500/yr - $18,500/yr

Starting position title and compensation are commensurate with experience.